Clinical Benefits and Adverse Effects of Vonoprazan in Long-Term Maintenance Therapy

Clinical Benefits and Adverse Effects of Vonoprazan in Long-Term Maintenance Therapy

Saved in:

Bibliographic Details
Main Author:	Jin Hee Noh
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2025-01-01
Series:	The Korean Journal of Gastroenterology
Online Access:	https://www.kjg.or.kr/journal/view.html?uid=6086&vmd=Full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication
by: Jin Hee Noh, et al.
Published: (2023-09-01)

Step-Down Therapy Using Vonoprazan for Giant Gastric Polyps in Long-Term Proton Pump Inhibitor Administration
by: Daisuke Kikuchi, et al.
Published: (2025-03-01)

Profound gastric mucosal changes and severe rebound acid hypersecretion after long‐term Vonoprazan use: A case report
by: Hiroko Suda, et al.
Published: (2025-04-01)

Efficacy of Step-Down Therapy Using Vonoprazan for Symptomatic Mild Reflux Esophagitis
by: Yorinari Ochiai, et al.
Published: (2024-01-01)

Fourteen-day vonoprazan-amoxicillin dual therapy versus 14-day bismuth-based quadruple therapy for treatment: a randomized clinical trial
by: Jin-Yan Zhang, et al.
Published: (2025-07-01)

ADVERSE EFFECTS OF LONG-TERM CORTICOSTEROID THERAPY OF NEPHROTIC SYNDROME IN CHILDREN
by: T. L. Nastausheva, et al.
Published: (2017-08-01)

Efficacy of Vonoprazan-Tetracycline Dual Therapy in the Initial Treatment of Penicillin-Allergic Helicobacter pylori Infections
by: Younghee Choe
Published: (2024-12-01)

Long-term controlled antihypertensive therapy in Chernobyl liquidators, its effectiveness and benefits
by: I. I. Razdobreeva, et al.
Published: (2005-06-01)

Vonoprazan–minocycline dual therapy as a first-line treatment of infection compared with empirical bismuth-containing quadruple therapy
by: Meng Li, et al.
Published: (2025-08-01)

Long-term gastrointestinal adverse effects of doxycycline
by: Khalid Eljaaly, et al.
Published: (2023-02-01)

Reduction of gastro-intestinal adverse effect risk in long-term therapy with acetylsalicylic acid
by: E. Yu. Bulakhova, et al.
Published: (2010-08-01)

Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori
by: Jing Yu, et al.
Published: (2024-11-01)

Severe Hypomagnesemia in a Patient Treated Using Carboplatin Co-Administered with Vonoprazan
by: Osamu Taniguchi, et al.
Published: (2025-01-01)

Efficacy and safety of vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for patients with Helicobacter pylori infection: a meta-analysis
by: Xiao Li, et al.
Published: (2025-03-01)

Vonoprazan-based therapy versus standard regimen for Helicobacter pylori infection management in Egypt: an open-label randomized controlled trial
by: Yumna M. Shekeban, et al.
Published: (2025-05-01)

Vonoprazan in the management of erosive oesophagitis and peptic ulcer-induced medication: a systematic review
by: Décio Chinzon, et al.
Published: (2021-12-01)

Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Endoscopic Hemostasis
by: Jin Lee
Published: (2024-09-01)

CLINICAL AND ECONOMIC ANALYSIS OF THE LONG-TERM MAINTENANCE THERAPY BY COMBINED DRUGS OF BRONCHIAL ASTHMA IN SCHOOL CHILDREN, RESIDENTS OF THE RURAL REGIONS
by: I.N. Ermakova, et al.
Published: (2011-08-01)

Translational switch for long‐term maintenance of synaptic plasticity
by: Naveed Aslam, et al.
Published: (2009-06-01)

The efficacy and safety of Vonoprazan and Tegoprazan in eradication: a comprehensive systematic review and meta-analysis of randomized controlled trials
by: Ting Jin, et al.
Published: (2025-01-01)

Modeling Maintenance of Long-Term Potentiation in Clustered Synapses: Long-Term Memory without Bistability
by: Paul Smolen
Published: (2015-01-01)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
by: Negin Kashani, et al.
Published: (2018-01-01)

Long-term outcomes of kidney transplantation in terms of different variants of maintenance immunosuppression
by: N. A. Tomilina, et al.
Published: (2016-02-01)

Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for <i>Helicobacter pylori</i> Infection: A Systematic Review
by: Chih-An Shih, et al.
Published: (2025-03-01)

The effect of maintenance therapy on Crohn’s disease clinical outcomes
by: O. B. Schukina, et al.
Published: (2018-08-01)

Tattooing: immediate and long-term adverse reactions and complications
by: Dodig Slavica, et al.
Published: (2024-12-01)

Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
by: Gabriella Fabbrocini, et al.
Published: (2022-07-01)

Long-term efficacy of therapeutic drug monitoring-guided optimization of ustekinumab maintenance therapy for Crohn’s disease patients
by: Haixia Ren, et al.
Published: (2025-07-01)

Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line eradication: a prospective multicenter randomized controlled trial
by: Ben-Gang Zhou, et al.
Published: (2024-12-01)

Long‐Term Maintenance of Complex Chromosomal Inversion Polymorphism in Drosophila mediopunctata
by: Fabiana Uno, et al.
Published: (2024-10-01)

Mini chamber system for long-term maintenance and observation of cultured cells
by: Chung-Liang Ho, et al.
Published: (2005-02-01)

The biophysical basis underlying the maintenance of early phase long-term potentiation.
by: Moritz F P Becker, et al.
Published: (2021-03-01)

Observation of the efficacy of long-term citrate anticoagulation in patients with maintenance hemodialysis
by: ZHUANG Feng, et al.
Published: (2020-01-01)

Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01)

Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial
by: William D Chey, et al.
Published: (2024-11-01)

Advances in the epidemiology of the effects of maternal obesity on long-term adverse health outcomes in offspring
by: Min-Jie ZHANG, et al.
Published: (2023-12-01)

Long-term benefits of TUDCA supplement in ARSACS zebrafish model
by: Valentina Naef, et al.
Published: (2025-07-01)

Optimizing physical education schedules for long-term health benefits
by: Liang Tan, et al.
Published: (2025-06-01)

Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects
by: Zhuo‐qun Ren, et al.
Published: (2025-06-01)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
by: Gerard Criner, et al.
Published: (2023-01-01)